DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Respiratory Kinematics During Voluntary and Reflex Cough in Healthy Adults

Information source: University of Florida
ClinicalTrials.gov processed this data on August 20, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Cough

Intervention: Healthy adults who receive capsaicin (Drug)

Phase: Phase 1/Phase 2

Status: Completed

Sponsored by: University of Florida

Official(s) and/or principal investigator(s):
Alexandra E. Brandimore, M.A., Principal Investigator, Affiliation: University of Florida

Summary

Cough is a defensive behavior that involves three stages. A large inspiratory phase, a compression phase where the vocal folds close and subglottal pressure is developed, and an expiratory phase. Cough serves to protect the upper and lower airways from material such as liquids, solids, or saliva, that have been aspirated. There are two types of cough: voluntary and reflex cough. Voluntary cough involves a cough to command. Reflex cough is a cough that is generated secondary to a stimulus in or near the airway. There has been some research regarding the differences between voluntary and reflex cough. However, no research has described the differences in airflow or movement pattern (kinematics) between the two types of cough. This study seeks to determine the respiratory kinematics and airflow differences between voluntary and reflex cough in healthy participants.

Clinical Details

Official title: Respiratory Kinematics During Voluntary and Reflex Cough in Healthy Adults

Study design: Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic

Primary outcome: Lung Volume Initiation

Secondary outcome:

Peak Expiratory Airflow Rate

Urge-to-cough

Detailed description: As a participant, completion of this study will require the following: Investigators will first place cotton elastic bands around your chest and abdomen so that measures of chest wall and abdominal movements can be measured. Then, tests of your breathing made from pulmonary function testing will be completed. Investigators will then have you complete a maximum inspiration followed by a maximum expiration three times. Investigators will ask you to produce a voluntary cough three times into a facemask which is attached to a computer. Then the investigators will provide you with nebulized water (FOG) through the facemask for up to a minute three times. You will have a minute break in between each presentation. Finally, the investigators will provide you with a nebulized dose of Capsaicin, which is derived from hot peppers, through the same facemask used in all of the above tasks. You will receive three doses of capsaicin and be provided with water at any time during the study.

Eligibility

Minimum age: 18 Years. Maximum age: 80 Years. Gender(s): Both.

Criteria:

Inclusion Criteria:

- Healthy adults between the ages of 18-80 years.

- Ability to provide informed consent.

Exclusion Criteria:

- No history of smoking within the last 5 years as this reduces the sensitivity to

capsaicin

- No history of neurological disease (i. e. Parkinson's disease, stroke, traumatic brain

injury, etc.)

- No known allergy to capsaicin

- No history of respiratory disease (i. e. asthma, chronic obstructive pulmonary

disease, or respiratory infection within the last 5 weeks.)

Locations and Contacts

University of Florida, Dauer Hall, Gainesville, Florida 32611, United States
Additional Information

Starting date: May 2013
Last updated: February 17, 2015

Page last updated: August 20, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017